PerkinElmer to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

PerkinElmer Inc., (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Tuesday, March 21, 2023 at 2:15 p.m. ET.

Steve Willoughby, senior vice president, investor relations & head of ESG, and Alan Fletcher, senior vice president, Life Sciences, will provide an update on the Company and its strategic priorities. To register, click here.

A live audio webcast will be available on the Events section of the Company’s website at www.perkinelmer.com. A replay of the presentation will be posted on the PerkinElmer Investor Relations website after the event and will be available for at least 30 days.

About PerkinElmer

PerkinElmer, Inc. is a global leader focused on innovating for a healthier world. The Company reported revenue of approximately $4.6 billion in 2022, has more than 16,000 employees serving customers in 190 countries, and is a component of the S&P 500 Index. Additional information is available at www.perkinelmer.com.

Contacts

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  208.84
+3.57 (1.74%)
AAPL  273.09
+6.91 (2.60%)
AMD  210.83
+14.23 (7.24%)
BAC  50.24
-0.83 (-1.62%)
GOOG  310.57
-1.12 (-0.36%)
META  637.69
+0.44 (0.07%)
MSFT  386.28
+1.81 (0.47%)
NVDA  192.06
+0.51 (0.27%)
ORCL  144.64
+3.33 (2.36%)
TSLA  403.30
+3.47 (0.87%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.